![David Myles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Myles
Directeur Technique/Scientifique/R&D chez
OLEMA PHARMACEUTICALS, INC.
Fortune : 9 M $ au 31/05/2026
Profil
David C.
Myles was the founder of Epiphany Biosciences, Inc., founded in 2006, where the title held was Chief Operating Officer from 2006 to 2008.
Current jobs include Chairman-Finance at Point Blue Conservation Science, Trustee at The Webb School of California, and Chief Scientific Officer at Olema Pharmaceuticals, Inc. starting in 2026.
Former jobs include Associate Director-Medical Chemistry at Chiron Corp.
from 1998 to 2001, Executive Director-Chemistry at Kosan Biosciences, Inc. from 2006 to 2007, and Assistant Professor at the University of California, Los Angeles from 1991 to 1998.
Education includes a doctorate from Yale University conferred in 1989 and an undergraduate degree from Occidental College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2026 | 700 438 ( 0,8% ) | 9 M $ | 31/05/2026 |
Postes actifs de David Myles
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/03/2026 |
The Webb School of California
 The Webb School of California Other Consumer ServicesConsumer Services Operates as a boarding and day school | Directeur/Membre du Conseil | - |
Point Blue Conservation Science | Directeur Financier/CFO | - |
Anciens postes connus de David Myles
| Sociétés | Poste | Fin |
|---|---|---|
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Fondateur | 01/01/2008 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Corporate Officer/Principal | 01/11/2007 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01/01/2001 |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1998 |
Formation de David Myles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products and diagnostic technologies | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Webb School of California
The Webb School of California Other Consumer ServicesConsumer Services Operates as a boarding and day school | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Point Blue Conservation Science |
